Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti- Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|11|1635-1645

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.11, 2012-04, pp. : 1635-1645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-06 ,pp. : 583-591

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-Based Drug Design Methodologies in Drug Discovery Process: An Overview

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 3, 2006-09 ,pp. : 155-165

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-Based Drug Discovery and Molecular Docking in Drug Design

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 1, 2015-01 ,pp. : 11-25

Bentham Science Publishers

Access to resources Recommend Favorite

New Methodologies for Ligand-Based Virtual Screening

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1189-1202

Bentham Science Publishers

Access to resources Recommend Favorite